Sun.Jul 28, 2024

article thumbnail

The Neural Signature of OCD Has Been Identified in The Human Brain

AuroBlog - Aurous Healthcare Clinical Trials blog

Researchers have discovered patterns in the brain that reflect the effectiveness of deep brain stimulation therapy for obsessive–compulsive disorder (OCD), potentially leading to improvements in the way that the condition is handled individually for each case.

Medicine 146
article thumbnail

Pharmaceutical Technology Excellence Awards 2024: SecureCHEK AI

Pharmaceutical Technology

SecureCHEK AI is a Category Award Winner in four areas in the 2024 Pharmaceutical Technology Excellence Awards

147
147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Indian pharma to take advantage of GenAI potential to streamline drug discovery, reduce cost & time-to-market

AuroBlog - Aurous Healthcare Clinical Trials blog

The Indian pharmaceutical industry is working to take advantage of Generative AI potential to transform drug discovery. Functions such as establishing connections between the causative pathways and showing the genetic predispositions have the potential to enable successful interventions and revert disease progression.

Genetics 152
article thumbnail

Boehringer Buys Nerio Therapeutics for $1.3B to Boost Immuno-Oncology Pipeline

BioSpace

Under the deal announced Monday with the California biotech, German pharma Boehringer Ingelheim is gaining access to novel immune checkpoint inhibitors designed to activate the immune system to fight cancer cells.

103
103
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

LEO closes on first approval for chronic hand eczema drug

pharmaphorum

The CHMP has backed LEO Pharma's delgocitinib for chronic hand eczema, considered to be one of its top pipeline prospects

Drugs 113
article thumbnail

FDA Flags Safety Risks of Compounded Versions of Novo’s Semaglutide, Reports Hospitalizations

BioSpace

The regulator on Friday warned healthcare providers and patients about adverse events linked with dosing errors from compounded versions of Novo Nordisk’s weight-loss and diabetes drugs.

More Trending

article thumbnail

Navigating Deaths During Clinical Trials

BioSpace

Fatalities are an unfortunate reality of clinical trials. How can companies best protect themselves?

article thumbnail

The Impact of International Trade Agreements on Drug Patents: A Systematic Review

Drug Patent Watch

The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) sets minimum standards for intellectual property protection globally, including patents […] Source

Drugs 70
article thumbnail

Exploring Tailored Alcohol Use Disorder Treatments – Get Involved Today!

Trialfacts

Contents About the Study Why Participate? Your Rights Who Can Participate? More Study Details About the Research Centre: Location Research Centre: Monash University Location: 770 Blackburn Rd, Clayton VIC 3168 Lead Researcher: Antonio Verdejo-Garcia HREC: This study has been reviewed and approved by the Monash University Human Ethics Research Committee About the Study Did you know that personalised treatments for Alcohol Use Disorder (AUD) could revolutionise recovery success rates?

article thumbnail

New tentative approval for Alembic drug dabigatran etexilate mesylate

Drug Patent Watch

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.

Drugs 52
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Skincare Industry Trends

Roots Analysis

In 1967, renowned zoologist Desmond Morris quoted, “Flawless skin is the most universally desired human feature”. According to him, social convention dictates that the well-being of human health and fertility are indicative of an even-toned, clear skin with a radiant complexion. While cosmetic procedures can effectively target specific aging concerns like deep wrinkles, sagging skin, and volume loss, they may not comprehensively improve the overall skin quality.

article thumbnail

Drug Patent Expirations for the Week of July 28, 2024

Drug Patent Watch

ALOXI (palonosetron hydrochloride) Helsinn hlthcare Patent: 7,947,725 Expiration: Jul 30, 2024 See More … For more information on how DrugPatentWatch […] Source

Drugs 52
article thumbnail

An Ominous Wave

JAMA Internal Medicine

This case report describes a man in his 40s with evidence of malignant J wave syndrome on electrocardiography.

40
article thumbnail

Which pharmaceutical companies have the most powder dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most powder dosed drugs. For a different perspective, see the most popular dosage types.

Drugs 52
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations